Barnett, Eugene Philip – Trademark Portfolio

Entity Type: 01

Barnett, Eugene Philip holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NANOBLU and THERALUMEN. The owner is based in Scottsdale, AZ.

5539 E Bloomfield Rd.

Scottsdale, AZ 85254

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Barnett, Eugene Philip's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Barnett, Eugene Philip have?

Barnett, Eugene Philip has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does Barnett, Eugene Philip file in?

Barnett, Eugene Philip files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Barnett, Eugene Philip's most well-known trademarks?

Barnett, Eugene Philip's registered trademark portfolio includes well-known marks such as NANOBLU and THERALUMEN. These are among 2 currently registered trademarks in the portfolio.

What is Barnett, Eugene Philip's trademark registration success rate?

Barnett, Eugene Philip has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.